
Conference Coverage
about 17 hours ago
Top 5 Takeaways From ESMO 2026 That Patients Should Knowabout 1 month ago
3 More Lung Cancer Breakthroughs From WCLC 2026about 1 month ago
Top 3 Takeaways From WCLC 2026 That Patients Should KnowLatest Content

CAR T-Cell Therapy for Relapsed Hairy Cell Leukemia

Life After Testicular Cancer: Faith, Purpose and a New Beginning

Top 5 Takeaways From ESMO 2026 That Patients Should Know

What Patients With Hairy Cell Leukemia Should Know About Infection Risk and Follow-Up Care

How to Read Cancer Trial Results: Survival Terms Explained

Shorts










Videos
All News

Dr. Robert J. Kreitman explains how an experimental CAR T-cell therapy may help patients with relapsed hairy cell leukemia achieve lasting remissions.

Dr. Jacqueline Barrientos discussed how collaboration, individualized treatment and patient advocacy helped a 72-year-old man achieve leukemia remission and receive a kidney transplant.

Adding Imdelltra to Imfinzi maintenance helped people with extensive-stage small cell lung cancer live a median of 21.1 months vs. 12.7 months with Imfinzi alone in the phase 3 DeLLphi-305 trial.

The FDA approved Talzenna plus Xtandi for adults with HRR-mutated metastatic prostate cancer that has not been treated with, or is still responding to, androgen pathway drugs.

New results for lung and pancreatic cancer show newer targeted drugs may help some patients live longer. Here is what patients and caregivers should know.

Two federal laws, the Family and Medical Leave Act and the Americans with Disabilities Act, can protect people with cancer and their caregivers at work. Here is who qualifies, what each law covers and how to ask for leave or changes at wor

An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.

After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.

Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.

Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.

The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.

Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.

A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.

After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.

Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.































